Skip to main content

Advertisement

SpringerLink
Log in

Orphan Nuclear Receptors in Colorectal Cancer

  • Review Paper
  • Published:
Pathology & Oncology Research

Abstract

Colorectal cancer is one of the most common cancers worldwide, with an overall increased incidence annually. Despite improvements in treatment and surveillance, almost 50% develop recurrent and/or distant disease. Unknown cellular processes are the fundamental cause for treatment failure and metastatic disease. The interplay of chronic inflammation and carcinogenesis is well established. Recent work has highlighted the role of nuclear receptors and co-regulators in the inflammation to carcinogenesis process. Orphan nuclear receptors have been shown to be involved in numerous cellular processes, including both at a transcriptional and a non-genomic level. There is a significant emphasis to identify ligands that will interact and modify these nuclear receptors, with the long-term aim of developing novel pharmaceutical therapies. The identification of orphan nuclear receptor ligands will also help increase our current understanding of their role in cellular signaling, by enabling manipulation of these receptors. This review aims to provide a brief overview of some key orphan nuclear receptors which may be involved in colorectal cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. National Cancer Intelligence Network Data Briefing, 2009. Colorectal Cancer Survival by Stage. [online] Available at http://www.ncin.org.uk/publications/data_briefings/colorectal_cancer_survival_by_stage.aspx

  2. Rizzo A, Pallone F, Monteleone G, Fantini MC (2011) Intestinal inflammation and colorectal cancer: a double edged sword? World J Gastroenterol 17:3092–3100

    PubMed  PubMed Central  Google Scholar 

  3. Riggins RB, Mazzotta MM, Maniya OZ, Clarke R (2010) Orphan nuclear receptors in breast cancer pathogenesis and therapeutic response. Endocr Relat Cancer 17(3):213–231

    Article  CAS  Google Scholar 

  4. Han YF, Cao GW (2012) Role of nuclear receptor NR4A2 in gastrointestinal inflammation and cancers. World J Gastroenterol 18(47):6865–6873

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357:539–545

    Article  PubMed  CAS  Google Scholar 

  6. Lee JS, Kim KI, Baek SH (2008) Nuclear receptors and co-regulators in inflammation and cancer. Cancer Lett 267:189–196

    Article  PubMed  CAS  Google Scholar 

  7. Safe S, Kim K, Li X, Lee SO (2011) NR4A orphan receptors and cancer. Nucl Recept Signal 9:1–14

    Google Scholar 

  8. Evans RM (2005) The nuclear receptor superfamily: a rosetta stone for physiology. Mol Endocrinol 19:1429–1438

    Article  PubMed  CAS  Google Scholar 

  9. Novac N, Heinzel T (2004) Nuclear receptors: overview and classification. Curr Drug Targets Inflamm Allergy 3:335–346

    Article  PubMed  CAS  Google Scholar 

  10. Robinson-Rechavi M, Garcia HE, Laudet V (2003) The nuclear receptor superfamily. J Cell Sci 116:585–586

    Article  PubMed  Google Scholar 

  11. Zhao Y, Bruemmer D (2010) NR4A Orphan Nuclear Receptors: Transcriptional regulators of gene expression in metabolism and vascular biology. Arterioscler Thromb Vasc Biol 30(8):1535–1541

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  12. Benoit G, Malewicz M, Perlmann T (2009) Digging deep into the pockets of orphan nuclear receptors: insights from structural studies. Trends Cell Biol Chem 284:23286–23292

    Google Scholar 

  13. Gallastegui N, Mackinnon JA, Fletterick RJ, Estébanez-Perpiñá E (2015) Advances in our structural understanding of orphan nuclear receptors.Trends Biochem Sci 2015;40(1):25–35

  14. Wu H, Lin Y, LI W, Sun Z, Gao W, Zhang H, Xie L, Jiang F, Qin B, Yan T, Chen L, Zhao Y, Cao X, Wu Y, Lin B, Zhou H, Wong AS, Zhang XK, Zeng JZ (2010) Regulation of Nurr 77 expression by beta-catenin and its mitogenic effect on colon cancer cells. FASEB J 25:192–205

    Article  PubMed  Google Scholar 

  15. Shi Y (2007) Orphan nuclear receptors in drug discovery. Drug Discov Today 12:440–445

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  16. Giguere V, Yang N, Segui P, Evans RM (1988) Identification of new class of steroid hormone receptor. Nature 331:91–94

    Article  PubMed  CAS  Google Scholar 

  17. Bookout AL, Jeong Y, Downes M, Yu RT, Evans RM (2006) Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell 126:789–799

    Article  PubMed  CAS  Google Scholar 

  18. Claessens F, Gewirth DT (2004) DNA recognition by nuclear receptors. Essays Biochem 40:59–72

    Article  PubMed  CAS  Google Scholar 

  19. Freedman LP, Luisi BF, Korszun ZR, Basavappa R, Sigler PB, Yamamoto KR (1988) The function and structure of the metal coordination sites within the glucocorticoid receptor DNA binding domain. Nature 334:543–546

    Article  PubMed  CAS  Google Scholar 

  20. Zelcer N, Tontonoz P (2006) Liver X receptors as integrators of metabolic and inflammatory signaling. J Clin Invest 116:607–614

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  21. Blumberg B, Evans RM (1998) Orphan nuclear receptors – new ligands and new possibilities. Genes Dev 12:3149–3155

    Article  PubMed  CAS  Google Scholar 

  22. Ordentlich P (2003) Identification of the antineoplastic agent 6-mercaptopurine as an activator of the orphan nuclear hormone receptor Nurr 1. J Biol Chem 278:24791–24799

    Article  PubMed  CAS  Google Scholar 

  23. Enmark E, Gustafsson JA (1996) Orphan nuclear receptors – the first eight years. Mol Endocrinol 10:1293–1307

    PubMed  CAS  Google Scholar 

  24. Boute N et al (2002) The use of resonance energy transfer in high-throughput screening. BRET versus FRET. Trend Pharmacol 23:351–354

    Article  CAS  Google Scholar 

  25. Xu HE et al (2002) Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha. Nature 415:813–817

    Article  PubMed  CAS  Google Scholar 

  26. Mohan HM, Aherne CM, Rogers AC, Baird AW, Winter DC, Murphy EP (2012) Molecular pathways: The role of NR4A Orphan Nuclear Receptors in Cancer. Clin Cancer Res 18:3223–3228

    Article  PubMed  CAS  Google Scholar 

  27. Hanahan D, Weinberg RA (2000) Cell 100:57–70

    Article  PubMed  CAS  Google Scholar 

  28. Martinez-Gonzalez J, Badimon L (2005) The NR4A subfamily of nuclear receptors: new early genes regulated by growth factors in vascular cells. Cardiovasc Res 65:609–618

    Article  PubMed  CAS  Google Scholar 

  29. Maxwell MA, Muscat GE (2006) The NR4A subgroup: immediate early response genes with pleiotropic physiological roles. Nucl Recept Signal 4:e002

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  30. Collins D, Hogan AM, Winter DC (2011) Microbial and viral pathogens in colorectal cancer. Lancet Oncol 12(5):504–512

    Article  PubMed  CAS  Google Scholar 

  31. Hogan AM, Kennelly R, Collins D et al (2009) Oestrogen inhibits human colonic motility by a non-genomic cell membrane receptor-dependent mechanism. Br J Surg 96(7):817–822

    Article  PubMed  CAS  Google Scholar 

  32. McMorrow JP, Murphy EP (2011) Inflammation: a role for NR4A orphan nuclear receptors? Biochem Soc Trans 39(2):688–693

    Article  PubMed  CAS  Google Scholar 

  33. Holla VR, Wu H, Shi Q, Menter DG, Dubois RN (2011) Nuclear orphan receptor NR4A2; Modulates fatty acid oxidation pathways in colorectal cancer. J Biol Chem 286(34):30003–30009

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  34. Han Y, Cai H, Ma L, Ding Y, Tan X, Liu Y, Su T, Yu Y, Chang W, Zhang H, Fu C, Cao G Nuclear orphan receptor NR4A2 confers chemoresistance and predicts unfavorable prognosis of colorectal carcinoma patients who received post-operative chemotherapy. Eur. J. Cancer. 2013; Jun 25. pii: S0959–8049(13)00461–9

  35. Li X, Tai HH (2009) Activation of thromboxane A2 receptors induces orphan nuclear receptors Nurr 1 expression and stimulates cell proliferation in human lung cancer cells. Carcinogenesis 30:1606–1613

    Article  PubMed  CAS  Google Scholar 

  36. Holla VR, Mann JR, Shi Q, Dubois RN (2006) Prostaglandin E2 regulates the nuclear receptor NR4A2 in colorectal cancer. J Biol Chem 281(5):2676–2268

    Article  PubMed  CAS  Google Scholar 

  37. Palorini R, De Rasmo D, Gaviraghi M, Danna LS, Signorile A, Cirulli C, Chiaradonna F, Alberghina L, Papa S. Oncogenic K-ras expression is associated with derangement of the cAMP/PKA pathway and forskolin-reversible alterations of mitochondrial dynamics and respiration. Oncogene 2012; 32(3):352–362

  38. Leone V, di Palma A, Ricchi P, Acquaviva F, Giannouli M, Di Prisco AM, Iuliano F, Acquaviva AM (2007) PGE2 inhibits apoptosis in human adenocarcinoma Caco-2 cell line through Ras-PI3K association and cAMP-dependant kinase A activation. Am J Physiol Gastrointest Liver Physiol 293:673–681

    Article  CAS  Google Scholar 

  39. Zagani R, Hamzaoui N, Cacheux W, de Reynies A, Terris B, Chaussade S, Romagnolo B, Perret C, Lamarque D (2009) Cyclooxygenase-2 inhibitors down-regulate osteopontin and NR4A2 new therapeutic targets for colorectal cancers. Gastroenterology 137:1358–1366

    Article  PubMed  CAS  Google Scholar 

  40. Takamoto N, You LR, Moses K, Chiang C, Zimmer WE, Schwartz RJ, DeMayo FJ, Tsai MJ, Tsai SY (2005) COUP-TFII is essential for radial and anteroposterior patterning of the stomach. Development 132:2179–2189

    Article  PubMed  CAS  Google Scholar 

  41. Hamers AA, van Dam L, Teixeira Duarte JM et al (2015) Defiency of nuclear receptors Nurr77 aggravates mouse experimental colitis by increased NFκB activity in marcophages. PLoS One 4;10(8):e0133598. https://doi.org/10.1371/journal.pone.0133598

  42. Liang R, Lin Y, Yuan CL, Liu ZH, Li YQ, Luo XL, Ye JZ, Ye HH (2018) High expression of estrogen-related receptor α is significantly associated with poor prognosis in patients with colorectal cancer. Oncol Lett 15(4):5933–5939

  43. Xiao L, Wang J, Li J, Chen X, Xu P, Sun S, He D, Cong Y, Zhai Y (2015) RORα inhibits adipocyte-conditioned medium-induced colorectal cancer cell proliferation and migration and chick embryo chorioallantoic membrane angiopoiesis. Am J Physiol Cell Physiol. 308(5):C385–96

  44. Berman AY, Manna S, Schwartz NS, Katz YE, Sun Y, Behrmann CA, Yu JJ, Plas DR, Alayev A, Holz MK (2017) ERRα regulates the growth of triple-negative breast cancer cells via S6K1-dependent mechanism. Signal Transduct Target Ther 2:e17035

  45. Shin D, Kim IS, Lee JM, Shin SY, Lee JH, Baek SH, Cho KH (2014) The hidden switches underlying RORα-mediated circuits that critically regulate uncontrolled cell proliferation. J Mol Cell Biol 6(4):338–348

  46. Wen Z, Pan T, Yang S, Liu J, Tao H, Zhao Y, Xu D, Shao W, Wu J, Liu X, Wang Y, Mao J, Zhu Y (2017) Up-regulated NRIP2 in colorectal cancer initiating cells modulates the Wnt pathway by targeting RORβ. Mol Cancer 16(1):20

  47. Wang C, Zhou Y, Ruan R, Zheng M, Han W, Liao L (2015) High expression of COUP-TF II cooperated with negative Smad4 expression predicts poor prognosis in patients with colorectal cancer. Int J Clin Exp Pathol 8(6):7112–7121

Download references

Author information

Author notes

  1. Michael E. Kelly and Helen M. Mohan contributed equally to this work.

Authors and Affiliations

  1. UCD Veterinary Sciences Centre, University College Dublin, Dublin 4, Ireland

    Michael E. Kelly, Helen M. Mohan & Alan W. Baird

  2. Centre for Colorectal Disease, St Vincent’s University Hospital, Elm Park, Dublin 4, Ireland

    Michael E. Kelly, Helen M. Mohan, Elizabeth J. Ryan & Des C. Winter

Authors
  1. Michael E. Kelly
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Helen M. Mohan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alan W. Baird
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Elizabeth J. Ryan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Des C. Winter
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael E. Kelly.

Ethics declarations

Conflict of interest

Authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kelly, M.E., Mohan, H.M., Baird, A.W. et al. Orphan Nuclear Receptors in Colorectal Cancer. Pathol. Oncol. Res. 24, 815–819 (2018). https://doi.org/10.1007/s12253-018-0440-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-018-0440-6

Keywords

Search

Navigation